Focal hepatic lesions: Diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging

Radiographics

Volumn 25, Issue 5, 2005, Pages 1299-1320

  Elsayes, Khaled M ^a,b   Narra, Vamsidhar R ^a   Yin, Yuming ^a   Mukundan, Govind ^a   Lammle, Markus ^a   Brown, Jeffrey J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b El Nile St Warak Elhadar   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

AGED; ECHO PLANAR IMAGING; FEMALE; HUMAN; IMAGE ENHANCEMENT; LIVER DISEASE; LIVER TUMOR; MALE; MIDDLE AGED; REVIEW; THREE DIMENSIONAL IMAGING;

AGED; CONTRAST MEDIA; ECHO-PLANAR IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 28144463448     PISSN: 15271323     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.255045180     Document Type: Review

References (73)

1. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999;212:876-884.
2. Kim MJ, Mitchell DG, Ito K, et al. Hepatic MR imaging: comparison of 2D and 3D gradient echo techniques. Abdom Imaging 2001;26:269-276.
3. vanSonnenberg E, Wroblicka JT, D'Agostino HB, et al. Symptomatic hepatic cysts: percutaneous drainage and sclerosis. Radiology 1994;190:387-392.
4. Mortelé KJ, Ros PR. Cystic focal liver lesions in the adult: differential CT and MR imaging features. RadioGraphics 2001;21:895-910.
5. Mathieu D, Vilgrain V, Mahfouz A, et al. Benign liver tumors. Magn Reson Imaging Clin N Am 1997;5:255-288.
6. Duvnjak M, Supanc V, Virovic L, et al. Caroli's disease. Acta Med Croatica 2003;57:249-252.
7. Zangger P, Grossholz M, Mentha G, et al. MRI findings in Caroli's disease and intrahepatic pigmented calculi. Abdom Imaging 1995;20:361-364.
8. Mercadier M, Chigot JP, Clot JP, et al. Caroli's disease. World J Surg 1984;8:22-29.
9. Asselah T, Ernst O, Sergent G, et al. Caroli's disease: a magnetic resonance cholangiopancreatography diagnosis. Am J Gastroenterol 1998;93:109-110.
10. Govil S, Justus A, Korah I, et al. Choledochal cysts: evaluation with MR cholangiography. Abdom Imaging 1998;23:616-619.
11. Pavone P, Laghi A, Catalano C, et al. Caroli's disease: evaluation with MR cholangiopancreatography. AJR Am J Roentgenol 1996;166:216-217.
12. Murphy BJ, Casillas J, Ros PR, et al. The CT appearance of cystic masses of the liver. RadioGraphics 1989;9:307-322.
13. Everson GT, Taylor MR, Doctor RB. Polycystic disease of the liver. Hepatology 2004;40:774-782.
14. Hussain SM, Zondervan PE, Ijzermans JN, Schalm SW, de Man RA, Krestin GP. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. RadioGraphics 2002;22:1023-1039.
15. Farmer DG, Rosove MH, Shaked A, et al. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994;219:236-247.
16. Livraghi T, Bolondi L, Lazzarona S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients. Cancer 1992;69:925-929.
17. Murakami T, Kuroda C, Marukawa T, et al. Regenerating nodules of hepatic cirrhosis: MR imaging with pathologic correlation. AJR Am J Roentgenol 1990;155:1227-1231.
18. Ohtomo K, Itai K, Ohtomo Y, et al. Regenerating nodules of liver cirrhosis: MR imaging with pathologic correlation. AJR Am J Roentgenol 1990;154:505-507.
19. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 1991;178:493-497.
20. Lee HM, Lu DSK, Krasny RM, et al. Hepatic lesion characterization in cirrhosis: significance of arterial phase hypervascularity on dual-phase helical CT. AJR Am J Roentgenol 1997;169:125-130.
21. Horton KM, Bluemke DA, Hruban RH, et al. CT and MR imaging of benign hepatic and biliary tumors. RadioGraphics 1999;19:431-451.
22. Allaire GS, Rabin L, Ishak KG, Sesterhenn IA. Bile duct adenoma: a study of 152 cases. Am J Surg Pathol 1988;12:708-715.
23. Semelka RC, Hussain SM, Marcos HB, et al. Biliary hamartomas: solitary and multiple lesions shown on current MR techniques including gadolinium enhancement. J Magn Reson Imaging 1999;10:196-201.
24. Cheung YC, Tan CF, Wan YL, et al. MRI of multiple biliary hamartomas. Br J Radiol 1997;70:527-529.
25. Parker SL, Tong T, Bolden S, et al. Cancer statistics. CA Cancer J Clin 1997;47:5-27.
26. Pedro MS, Semelka RC, Braga L. MR imaging of hepatic metastases. Magn Reson Imaging Clin N Am 2002;10:15-29.
27. Semelka RC, Braga L, Armao D, et al. Liver. In: Semelka RC, ed. Abdominal-pelvic MRI. New York, NY: Wiley-Liss, 2002; 101-134.
28. Nino-Murcia M, Olcott EW, Jeffrey RB Jr, et al. Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT. Radiology 2000;215:746-751.
29. Danet IM, Semelka RC, Leonardou P, et al. Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 2003;181:809-817.
30. Imam K, Bluemke DA. MR imaging in the evaluation of liver metastases. Magn Reson Imaging Clin N Am 2000;8:741-767.
31. Levy AD. Malignant liver tumors. Clin Liver Dis 2002;6:147-164.
32. Thomas JL, Bernardino ME, Vermess M, et al. EOE-13 in the detection of hepatosplenic lymphoma. Radiology 1982;145:629-634.
33. Zornoza J, Ginaldi S. Computed tomography in hepatic lymphoma. Radiology 1981;138:405-410.
34. Gazelle GS, Lee MJ, Hahn PF, et al. US, CT, and MRI of primary and secondary liver lymphoma. J Comput Assist Tomogr 1994;18:412-415.
35. Weissleder R, Stark DD, Elizondo G, et al. MRI of hepatic lymphoma. Magn Reson Imaging 1988;6:675-681.
36. Kelekis NL, Semelka RC, Siegelman ES, et al. Focal hepatic lymphoma: magnetic resonance demonstration using current techniques including gadolinium enhancement. Magn Reson Imaging 1997;15:625-636.
37. Warshauer DM, Lee JK. Imaging manifestations of abdominal sarcoidosis. AJR Am J Roentgenol 2004;182:15-28.
38. Lehmuskallio E, Hannuksela M, Halme H. The liver in sarcoidosis. Acta Med Scand 1977;202:289-293.
39. Klatskin G. Hepatic granulomata: problems in interpretation. Ann N Y Acad Sci 1976;278:427-432.
40. Kessler A, Mitchell DG, Israel HL, et al. Hepatic and splenic sarcoidosis: ultrasound and MR imaging. Abdom Imaging 1993;18:159-163.
41. Warshauer DM, Molina PL, Hamman SM, et al. Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. Radiology 1995;195:757-762.
42. Balci NC, Sirvanci M. MR imaging of infective liver lesions. Magn Reson Imaging Clin N Am 2002;10:121-135.
43. Ralls PW. Inflammatory disease of the liver. Clin Liver Dis 2002;6:203-225.
44. Ralls PW. Focal inflammatory disease of the liver. Radiol Clin North Am 1998;36:377-389.
45. Baker RD. Histoplasmosis in routine autopsies. Am J Clin Pathol 1964;41:457-470.
46. Xu H, Jiang D, Yang L, et al. The value of inphase and opposed-phase T1-weighted breathhold FLASH sequences for hepatic imaging. J Tongji Med Univ 2000;20:290-293.
47. Kemper J, Jung G, Poll LW, et al. CT and MRI findings of multifocal hepatic steatosis mimicking malignancy. Abdom Imaging 2002;27:708-710.
48. Ohtomo K, Baron RL, Dodd GD 3rd, et al. Con-fluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 1993;189:871-874.
49. Yang DM, Kim HS, Cho SW, et al. Various causes of hepatic capsular retraction: CT and MR findings. Br J Radiol 2002;75:994-1002.
50. Semelka RC, Ascher SM, Reinhold C. MRI of the abdomen and pelvis: a text-atlas. New York, NY: Wiley-Liss, 1997; 73-82.
51. Matsumoto Y, Suzuki T, Asada I, et al. Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels. Cancer 1982;49:354-360.
52. Yu SC, Yeung DT, So NM. Imaging features of hepatocellular carcinoma. Clin Radiol 2004;59:145-156.
53. Hussain SM, Semelka RC, Mitchell DG. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am 2002;10:31-52.
54. Kadoya M, Matsui O, Takashima T, et al. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 1992;183:819-825.
55. Quillin SP, Atilla S, Brown JJ, et al. Characterization of focal hepatic masses by dynamic contrastenhanced MR imaging: findings in 311 lesions. Magn Reson Imaging 1997;15:275-285.
56. Schlund JF, Semelka RC, Kettritz U, et al. Correlation of perfusion abnormalities on CTAP and immediate postintravenous gadolinium-enhanced gradient echo MRI. Abdom Imaging 1996;21:49-52.
57. Schlund JF, Semelka RC, Kettritz U, et al. Transient increased segmental hepatic enhancement distal to portal vein obstruction on dynamic gadolinium-enhanced gradient recalled echo MR images. J Magn Reson Imaging 1995;5:375-377.
58. Hussain SM, Terkivatan T, Zondervan PE, et al. Focal nodular hyperplasia: findings at state-of-theart MR imaging, US, CT, and pathologic analysis. RadioGraphics 2004;24:3-17.
59. Ichikawa T, Federle MP, Grazioli L, et al. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology 1999;213:352-361.
60. Mortelé KJ, Segatto E, Ros PR. The infected liver: radiologic-pathologic correlation. RadioGraphics 2004;24:937-955.
61. Grazioli L, Olivetti L, Fugazzola C, et al. The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Radiol 1999;9:62-67.
62. de Baere T, Denys A, Wood BJ, et al. Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems. AJR Am J Roentgenol 2001;176:187-192.
63. Braga L, Semelka RC, Pedro MS, et al. Post-treatment malignant liver lesions: MR imaging. Magn Reson Imaging Clin N Am 2002;10:53-73.
64. Mitchell DG, Rubin R, Siegelman ES, et al. Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images. Radiology 1991;178:101-103.
65. Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 1994;190:49-52.
66. Hagiwara A, Inoue Y, Shutoh T, et al. Haemorrhagic hepatic cyst: a differential diagnosis of cystic tumour. Br J Radiol 2001;74:270-272.
67. Semelka RC, Sofka CM. Hepatic hemangiomas. Magn Reson Imaging Clin N Am 1997;5:241-253.
68. Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 2001;176:1499-1507.
69. Manfredi R, Masselli G, Maresca G, et al. MR imaging and MRCP of hilar cholangiocarcinoma. Abdom Imaging 2003;28:319-325.
70. Radin DR, Kanel GC. Peliosis hepatis in a patient with human immuno-deficiency virus infection. AJR Am J Roentgenol 1991;156:91-92.
71. Smathers RL, Heiken JP, Lee JK, et al. Computed tomography of fatal hepatic rupture due to peliosis hepatis. J Comput Assist Tomogr 1984;8:768-769.
72. Maves CK, Caron KH, Bisset GS 3rd, et al. Splenic and hepatic peliosis: MR findings. AJR Am J Roentgenol 1992;158:75-76.
73. Yekeler E, Dursun M, Tunaci A, Cevikbas U, Rozanes I. Diagnosing of peliosis hepatis by magnetic resonance imaging. J Hepatol 2004;41:351.